Biography
Dr Hay is a qualitative research associate exploring the experiences of musculoskeletal pain in children and young people. This research takes in the perspectives of children and young people, their parents, and healthcare professionals, resulting in a detailed depiction of the current landscape of the experiences of musculoskeletal pain in children and young people and its management in primary healthcare in the UK.
This research is part of a larger programme which, among other things, will deliver information resources for children and young people and their families regarding living with musculoskeletal pain and getting better use out of primary healthcare.
Charles is also the co-founder of the Creative Methods and Dissemination Group based at Keele University which now has members from across the country.
Prior to his current work, completed a PhD exploring diagnostic delay in axial spondyloarthritis.
Charles’ involvement in health care research began in 2016, with a research assistant role in the now School of Medicine at Keele University. Before this Charles worked in archaeology across the UK.
Research and scholarship
Charles' current research with the NIHR-funded CAM-Pain programme focuses on the experience of musculoskeletal pain in children and young people, and the management and information needs that come with it.
The perspectives of children and young people and their guardians, and primary care HCPs and AHPs were addressed through qualitative study. The results of this study are now informing design, testing and production of information resources to help pain management for CYP and to improve the use of primary healthcare.
Patient and public involvement and engagement (PPIE) has played a large part in the design and undertaking of the CAM-Pain programme throughout, reflecting the importance of stakeholder inclusion in research and resource development.
Charles' PhD explored diagnostic delay in axial spondyloarthritis (axSpA), an auto-inflammatory condition with a long and often complex path to diagnosis. It comprised a systematic review presenting global levels of diagnostic delay in the disease, a qualitative study presenting patient and HCP perspectives on the barriers to and facilitators of diagnosis of axSpA and a case-control study showing possible associated prodromes to axSpA diagnosis. The systematic review has been published in Clinical Rheumatology in 2022 and the qualitative study was published in Rheumatology International in 2024.
Charles' previous research has covered mortality associated with allopurinol use in patients with gout and diagnostic delay in rheumatoid arthritis.
Publications
School of Medicine
David Weatherall building
University Road
Keele University
Staffordshire
ST5 5BG
Tel: +44 (0) 1782 733937
Email: fmhs.facilities@keele.ac.uk
Admissions enquiries: enquiries@keele.ac.uk
The Clinical Education Centre
Keele University
Clinical Education Centre
University Hospitals of North Midlands NHS Trust
Newcastle Road
Stoke-on-Trent
Staffordshire
ST4 6QG
Email us: services.cecreception@keele.ac.uk
CEC general enquires: 01782 731876